Skip to main content
Premium Trial:

Request an Annual Quote

InforSense, GenomeQuest Sign Informatics Integration Pact

NEW YORK (GenomeWeb) - InforSense and GenomeQuest have agreed to integrate their software and database products to help customers analyze and share data in different domains, InforSense said today.
 
As part of the agreement, GenomeQuest has joined the InforSense Open Workflow Partner Network.
 
GenomeQuest's platform is used for analyzing sequence-based biological and patent content from private and public resources, while InforSense offers a workflow-based analytic technology.
 
InforSense said its customers will now be able to access GenomeQuest’s sequence and patent record databases through the InforSense platform.
 
The integrated solution will allow "attorneys, researchers, and business managers to identify promising research opportunities quickly and accurately," InforSense said.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.